Unknown

Dataset Information

0

The ?-synuclein hereditary mutation E46K unlocks a more stable, pathogenic fibril structure.


ABSTRACT: Aggregation of ?-synuclein is a defining molecular feature of Parkinson's disease, Lewy body dementia, and multiple systems atrophy. Hereditary mutations in ?-synuclein are linked to both Parkinson's disease and Lewy body dementia; in particular, patients bearing the E46K disease mutation manifest a clinical picture of parkinsonism and Lewy body dementia, and E46K creates more pathogenic fibrils in vitro. Understanding the effect of these hereditary mutations on ?-synuclein fibril structure is fundamental to ?-synuclein biology. We therefore determined the cryo-electron microscopy (cryo-EM) structure of ?-synuclein fibrils containing the hereditary E46K mutation. The 2.5-Å structure reveals a symmetric double protofilament in which the molecules adopt a vastly rearranged, lower energy fold compared to wild-type fibrils. We propose that the E46K misfolding pathway avoids electrostatic repulsion between K46 and K80, a residue pair which form the E46-K80 salt bridge in the wild-type fibril structure. We hypothesize that, under our conditions, the wild-type fold does not reach this deeper energy well of the E46K fold because the E46-K80 salt bridge diverts ?-synuclein into a kinetic trap-a shallower, more accessible energy minimum. The E46K mutation apparently unlocks a more stable and pathogenic fibril structure.

SUBMITTER: Boyer DR 

PROVIDER: S-EPMC7035510 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

The α-synuclein hereditary mutation E46K unlocks a more stable, pathogenic fibril structure.

Boyer David R DR   Li Binsen B   Sun Chuanqi C   Fan Weijia W   Zhou Kang K   Hughes Michael P MP   Sawaya Michael R MR   Jiang Lin L   Eisenberg David S DS  

Proceedings of the National Academy of Sciences of the United States of America 20200203 7


Aggregation of α-synuclein is a defining molecular feature of Parkinson's disease, Lewy body dementia, and multiple systems atrophy. Hereditary mutations in α-synuclein are linked to both Parkinson's disease and Lewy body dementia; in particular, patients bearing the E46K disease mutation manifest a clinical picture of parkinsonism and Lewy body dementia, and E46K creates more pathogenic fibrils in vitro. Understanding the effect of these hereditary mutations on α-synuclein fibril structure is f  ...[more]

Similar Datasets

| EMPIAR-10494 | biostudies-other
| S-EPMC8556266 | biostudies-literature
| S-EPMC7250837 | biostudies-literature
| S-EPMC3591419 | biostudies-literature
| S-EPMC8158012 | biostudies-literature
| S-EPMC5034296 | biostudies-literature
| S-EPMC3605821 | biostudies-other
| S-EPMC7118165 | biostudies-literature
| S-EPMC2910156 | biostudies-literature
| S-EPMC6594597 | biostudies-literature